SCHEMBL5769360

SCHEMBL5769360

O=C(Cc1ccc(C(F)(F)F)cc1Cl)OC(=O)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.42
DAO P14920 1/20 0.41
MRGPRX4 Q96LA9 10/20 0.41
ALDH1A1 P00352 1/20 0.40
KCNJ5 P48544 1/20 0.40
KCNJ3 P48549 1/20 0.40
LMNA P02545 1/20 0.40
FFAR1 O14842 2/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
PDE2A O00408 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL835012 0.82 MAPT (0.51) P2RX7DAOMRGPRX4ALDH1A1KCNJ5
SCHEMBL5415002 0.80 RXRA (0.43) P2RX7DAOMRGPRX4ALDH1A1KCNJ5
SCHEMBL14755023 0.79 KCNJ5 (0.47) ALDH1A1KCNJ5KCNJ3LMNAMAPT
SCHEMBL838070 0.79 RXRA (0.50) P2RX7DAOMRGPRX4ALDH1A1KCNJ5
SCHEMBL29718989 0.79 RXRA (0.50) P2RX7DAOMRGPRX4ALDH1A1KCNJ5
Trifluoroacetic Acid SCHEMBL5769358 0.78 FFAR1 (0.47) P2RX7DAOMRGPRX4ALDH1A1KCNJ5
SCHEMBL31434971 0.77 DAO (0.46) P2RX7DAOMRGPRX4ALDH1A1KCNJ5
SCHEMBL3208015 0.71 PDE2A (0.49) P2RX7DAOMRGPRX4ALDH1A1LMNA
SCHEMBL2669965 0.71 DAO (0.51) P2RX7DAOMRGPRX4LMNAPDE2A
SCHEMBL30523915 0.71 PDE2A (0.49) P2RX7DAOMRGPRX4ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1687306-A1 BICYCLIC PYRIMIDIN-4-(3H)-ONES AND ANALOGUES AND DERIVATIVES THEREOF WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2006-08-09 EP disclosed
WO-2005049613-A1 BICYCLIC PYRIMIDIN-4-(3H)-ONES AND ANALOGUES AND DERIVATIVES THEREOF WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2005-06-02 WO disclosed